Results 171 to 180 of about 40,764 (311)

Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center.

open access: yesJournal of Thoracic and Cardiovascular Surgery, 2019
K. Hodges   +7 more
semanticscholar   +1 more source

Update on left ventricular outflow tract obstruction. [PDF]

open access: yesJ Cardiovasc Imaging
Song JK, Sun BJ, Kim DH, Jung SH.
europepmc   +1 more source

The Inflexible Mitral Annulus After Valve Prosthesis Inherent Risk of Dynamic Left Ventricular Outflow Tract Obstruction

open access: bronze, 1996
Takeshi Komoda   +8 more
openalex   +1 more source

Prognostic Value of Coronary Angiography‐Derived Index of Microvascular Resistance in Patients With Hypertrophic Cardiomyopathy

open access: yesMedComm, Volume 6, Issue 8, August 2025.
With an angio‐IMR threshold of over 25, nearly one‐third of HCM patients demonstrated CMD in the LAD. Patients with LAD angio‐IMR > 25 exhibited a higher incidence of MACE compared to those with LAD angio‐IMR ≤ 25 (cumulative incidence, 25.4% vs. 13.3%, p = 0.035).
Yuxuan Zhang   +17 more
wiley   +1 more source

Correction: Update on left ventricular outflow tract obstruction. [PDF]

open access: yesJ Cardiovasc Imaging
Song JK, Sun BJ, Kim DH, Jung SH.
europepmc   +1 more source

Rare Form of Right Ventricular Outflow Tract Obstruction [PDF]

open access: bronze, 2004
Ryan W. Zuzek   +3 more
openalex   +1 more source

Clinical Results for Cardiovascular Xenografts Treated With Novel Anticalcification Protocols

open access: yesArtificial Organs, Volume 49, Issue 8, Page 1307-1313, August 2025.
This study demonstrates the safety, efficacy, and clinical performance of the tissue‐engineered Periborn bovine pericardial scaffold treated with our novel anticalcification protocols for surgical repair of a variety of cardiovascular diseases. The overall probability of freedom from Periborn‐related reoperation was 95.4% ± 3.2% at 9 years.
Hong‐Gook Lim   +4 more
wiley   +1 more source

Advancing antihypertensive drug development

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 15, Page 3389-3410, August 2025.
Hypertension affects more than a billion individuals worldwide and remains a major cause of cardiovascular morbidity and mortality. Despite advances in therapies, optimal blood pressure control remains elusive for many patients because of treatment resistance, adverse effects, and adherence challenges.
Fay Pu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy